SUGCT
protein-codingsuccinyl-CoA:glutarate-CoA transferase
Gene summary
This gene encodes a protein that is similar to members of the CaiB/baiF CoA-transferase protein family. Mutations in this gene are associated with glutaric aciduria type III. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010]
- C7orf10
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~725.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009283
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009283
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009283
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009283
Submitter: ClinGen
*SUGCT* was first reported in relation to autosomal recessive glutaric acidemia type 3 in 2008 (Sherman EA, et al., 2008, PMID: 18926513). SUGCT catalyzes the succinyl-CoA-dependent conversion of glutaric acid into glutaryl-CoA preventing urinary loss of the organic acid; in patients with deficiency of SUGCT there is a consequent accumulation of glutaric acid. Glutaric aciduria type 3 is a biochemical phenotype with uncertain clinical relevance. Evidence supporting the relationship between *SUGCT* and glutaric acidemia type 3 includes case-level data and experimental data. Variants in this gene have been reported in at least 12 probands in 6 publications (PMIDs: 18926513, 28766179, 29421601, 2779420, 37920852, 39101156). At least 7 unique missense, nonsense, and frameshift variants have been reported in humans. This gene-disease relationship is supported by the biochemical function of *SUGCT* which is consistent with the biochemical abnormalities observed in individuals with glutaric acidemia type 3 (PMID: 23893049) and the biochemical features of a Sugct knockout mouse (PMID: 31722069). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This gene-disease pair was previously evaluated by the Aminoacidopathy GCEP on 09/25/2020. It was reevaluated on 10/14/2022 and 12/10/2024 which identified three additional cases (PMIDs: 37920852, 39101156). As a result of this reevaluation, the classification remained Moderate.
Inheritance Pattern: AR
Disease ID:MONDO:0009283
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: The clinical significance of the condition is unclear
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SUGCT variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001193313.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 25 | 2 | 27 | |||
| missense | 79 | 9 | 88 | |||
| nonsense | 1 | 3 | 3 | 7 | ||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 3 | |||
| Total | 1 | 5 | 85 | 34 | 2 | 127 |
Highest pathogenic variant AF is 0.00022272885
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001180242.2 | 14 | MANE Select | |
| Ensembl | ENSP00000338475.5 | 14 | MANE Select | |
| RefSeq | NP_001180240.2 | 15 | Standard | |
| RefSeq | NP_001180241.2 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Molecular Function
- protein binding
- succinate-hydroxymethylglutarate CoA-transferase activity
Cellular Component
- mitochondrion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000309930
- Coding exons
- 15
- Length
- 725788
- Individuals with no LoFs
- 124469
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 177
- Defined
- 124646
- p
- 0.000710
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.536 | 225 | 249 | 0.904 | 0.0000126 | 3014 |
| Missense (PolyPhen) | 105 | 96.978 | 1.0827 | 1134 | ||
| Synonymous | -0.0266 | 95 | 94.7 | 1.00 | 0.00000532 | 921 |
| Loss of Function | 1.44 | 17 | 24.7 | 0.688 | 0.00000129 | 318 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0010 | 0.0010 | notable |
| Latino/Admixed American | 0.00042 | 0.00041 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.0025 | 0.0025 | notable |
| Finnish | 0.00085 | 0.00084 | rare |
| European (Non-Finnish) | 0.00046 | 0.00045 | rare |
| South Asian | 0.00099 | 0.00088 | rare |
| Other | 0.00086 | 0.00083 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the succinyl-CoA-dependent conversion of glutarate to glutaryl-CoA. Can use different dicarboxylic acids as CoA acceptors, the preferred ones are glutarate, succinate, adipate, and 3-hydroxymethylglutarate. {ECO:0000269|PubMed:23893049}.;
Recessive Scores
- pRec
- 0.171
Intolerance Scores
- RVIS EVS
- 0.02
- RVIS percentile EVS
- 55.45
Essentials
- Essential (gene trap)
- N
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |